Biodegradability of synthetic branched polypeptide with poly(L-lysine) backbone. 1989

F Hudecz, and S Kutassi-Kovács, and G Mezö, and M Szekerke
Eötvös Loránd Tudományegyetem, Szerves Kémiai Tanszék, Budapest.

A detailed investigation is reported about the biodegradation of poly[Lys(DL-Alam)], m approximately 3, (AK) the common inside area of a branched polypeptide model system developed by our group over the last decade. Enzymatic hydrolysis was carried out by the exopeptidase aminopeptidase M, or the endopeptidase trypsin, or their mixture. Ion-exchange column chromatography, paper electrophoresis and thin-layer chromatography were utilised to achieve separation of metabolites. Breakdown products were identified by the aid of synthetic oligopeptides representing the potential fragments (DL-Ala2, DL-Ala3, Lys(DL-Alam), m = 1-3). The kinetics and the degree of enzymatic degradation were determined. The ratio of peptide/amino acid amounts in the hydrolysate was found to be 1.07 after 24 h treatment with aminopeptidase M, 3.0 with trypsin and 1.3 with aminopeptidase - trypsin mixture. The overall results indicated that the proteolysis of AK by an aminopeptidase M and trypsin mixture proceeds stepwise at multiple sites on the polypeptide chain. The degradation is significantly retarded as compared to that of alpha- or epsilon-polylysine. A mechanism of degradation is suggested based on the experimental results.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011107 Polylysine A peptide which is a homopolymer of lysine. Epsilon-Polylysine,Poly-(Alpha-L-Lysine),Epsilon Polylysine
D002852 Chromatography, Ion Exchange Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins. Chromatography, Ion-Exchange,Ion-Exchange Chromatography,Chromatographies, Ion Exchange,Chromatographies, Ion-Exchange,Ion Exchange Chromatographies,Ion Exchange Chromatography,Ion-Exchange Chromatographies
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D004590 Electrophoresis, Paper Electrophoresis in which paper is used as the diffusion medium. This technique is confined almost entirely to separations of small molecules such as amino acids, peptides, and nucleotides, and relatively high voltages are nearly always used. Paper Electrophoresis
D000409 Alanine A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM. Abufène,Alanine, L-Isomer,L-Alanine,Alanine, L Isomer,L Alanine,L-Isomer Alanine

Related Publications

F Hudecz, and S Kutassi-Kovács, and G Mezö, and M Szekerke
January 1995, Biomedical peptides, proteins & nucleic acids : structure, synthesis & biological activity,
F Hudecz, and S Kutassi-Kovács, and G Mezö, and M Szekerke
January 1990, Bioconjugate chemistry,
F Hudecz, and S Kutassi-Kovács, and G Mezö, and M Szekerke
October 2003, Biopolymers,
F Hudecz, and S Kutassi-Kovács, and G Mezö, and M Szekerke
December 1994, Journal of nuclear biology and medicine (Turin, Italy : 1991),
F Hudecz, and S Kutassi-Kovács, and G Mezö, and M Szekerke
May 2024, Bioengineering & translational medicine,
F Hudecz, and S Kutassi-Kovács, and G Mezö, and M Szekerke
April 2017, ACS combinatorial science,
F Hudecz, and S Kutassi-Kovács, and G Mezö, and M Szekerke
December 1972, Indian journal of biochemistry & biophysics,
F Hudecz, and S Kutassi-Kovács, and G Mezö, and M Szekerke
September 1977, Biochimica et biophysica acta,
F Hudecz, and S Kutassi-Kovács, and G Mezö, and M Szekerke
January 1987, Voprosy virusologii,
F Hudecz, and S Kutassi-Kovács, and G Mezö, and M Szekerke
May 1973, Biopolymers,
Copied contents to your clipboard!